| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
5,298 |
249 |
$1.14M |
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
4,176 |
328 |
$923K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
1,601 |
123 |
$393K |
| A4657 |
Syringe, with or without needle, each |
436 |
266 |
$96K |
| 85048 |
|
92 |
73 |
$26K |
| 85041 |
|
78 |
62 |
$21K |
| 83970 |
|
94 |
79 |
$19K |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
40 |
25 |
$11K |
| 82728 |
|
27 |
26 |
$5K |
| 83550 |
|
15 |
14 |
$1K |
| 83540 |
|
15 |
14 |
$1K |